This case-based virtual activity will focus on treatment and management of patients with advanced/metastatic basal cell skin cancer. In the program, we will look at pathogenic drivers of BCC including cellular signaling pathways and immune dysfunction, assess a variety of therapeutic approaches for the treatment of these tumors, and review clinical data for current and emerging agents, with the goal of improving practice habits in the management of BCC.